Latest News & Features
Americas
Industrial gases company Praxair has been cleared of patent infringement in a district court ruling after Mallinckrodt accused the company of infringing its respiratory treatment Inomax (nitric oxide). 6 September 2017
article
The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston. 5 September 2017
Americas
Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have entered a second round of litigation against Kite, a company which specialises in cancer immunotherapy treatments. 5 September 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc. 5 September 2017
Americas
Inventiva, a biopharmaceutical company that develops innovative therapies, has announced the extension of an agreement with AbbVie to continue to research and develop orally available RORγ inverse agonists. 4 September 2017
Americas
Indivior, which specialises in addiction treatment drugs, intends to launch an appeal against a US District Court for the District of Delaware verdict that could lead to rival companies selling a generic version of its Suboxone Film, a drug to treat opioid addiction. 4 September 2017
Americas
The California Life Sciences Association (CLSA), an advocacy group, has added six new members to its board of directors. 1 September 2017
Americas
Bayer HealthCare has filed a lawsuit against Nektar Therapeutics and Baxalta seeking a declaration that a treatment for haemophilia A does not infringe their patent. 31 August 2017
Asia-Pacific
The Australian government has rejected proposals by the Productivity Commission regarding extending the length of pharmaceutical patents. 31 August 2017
Americas
The Federal Trade Commission has approved a final order combating the anticompetitive effects resulting from Baxter’s proposed $625 million acquisition of Claris’s injectable drugs business. 31 August 2017